pharmaphorum editor in chief Jonah Comstock takes on the Health Innovators series with a conversation with Amy Bucher, chief behavioral officer at Lirio and author of “Engaged: Designing fo
For years, digital health has been heralded as the saviour of health services and the answer to patient engagement. Now the conversation is changing from what technology can do, to what it
Servier’s vorasidenib has shown efficacy in the treatment of low-grade glioma – a notoriously hard-to-treat form of brain cancer – although safety data has taken some of t
Health systems globally have reached a critical inflexion point, where ageing populations and tightening budgets mean we can no longer continue to purely treat late-stage symptomatic diseas